Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,984 | -22,863 | -76,173 | -51,842 | -33,204 |
| Depreciation Amortization | 4,614 | 492 | 1,710 | 6,195 | 767 |
| Accounts receivable | -1,443 | 5,349 | -27,439 | -11,208 | -17,354 |
| Accounts payable and accrued liabilities | 833 | -5,017 | 7,369 | 2,385 | 696 |
| Other Working Capital | 6,135 | 4,714 | 8,420 | 3,089 | -29 |
| Other Operating Activity | 10,681 | 5,058 | 37,534 | 15,507 | 22,421 |
| Operating Cash Flow | $-31,164 | $-12,267 | $-48,579 | $-35,874 | $-26,703 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,500 | N/A | 10,200 | 4,200 | 4,200 |
| PPE Investments | -91 | -88 | -406 | -357 | -191 |
| Sale Of Investment | 475 | 475 | 7,925 | 6,025 | 3,950 |
| Purchase Sale Intangibles | N/A | N/A | -53,368 | -53,368 | -52,633 |
| Other Investing Activity | 0 | 0 | -53,368 | -53,368 | -52,633 |
| Investing Cash Flow | $-3,116 | $387 | $-35,649 | $-43,500 | $-44,674 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 78,061 | 78,061 | 78,845 |
| Common Stock Issued | 61,555 | 61,168 | 23,919 | 15,553 | 6,363 |
| Other Financing Activity | -4,664 | -2,508 | -17,610 | -17,186 | -20,736 |
| Financing Cash Flow | $56,891 | $58,660 | $84,370 | $76,428 | $64,472 |
| Exchange Rate Effect | -91 | -103 | 130 | 121 | 154 |
| Beginning Cash Position | 29,295 | 29,295 | 29,023 | 29,023 | 29,023 |
| End Cash Position | 51,816 | 75,972 | 29,295 | 26,198 | 22,272 |
| Net Cash Flow | $22,521 | $46,677 | $272 | $-2,825 | $-6,751 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,164 | -12,267 | -48,579 | -35,874 | -26,703 |
| Capital Expenditure | -91 | -88 | -406 | -357 | -191 |
| Free Cash Flow | -31,255 | -12,355 | -48,985 | -36,231 | -26,894 |